跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞吉赛 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Hemofiltration Replacement Fluid of Sodium Citrate
Approved
化学药品
Hemofiltration Replacement Fluid of Sodium Citrate
Baxter Holding BV
🇨🇳 National Medical Products Administration
Approval Date
May 19, 2021
Approval ID
887M32hPnv9
Company
Baxter Holding BV
Type
化学药品
Approval Details
Approval Id
887M32hPnv9
Approval Number
国药准字HJ20210035
Generic Name
枸橼酸钠血滤置换液
Generic Name En
Hemofiltration Replacement Fluid of Sodium Citrate
Brand Name
瑞吉赛
Drug Type
化学药品
Dosage Form
注射剂
Strength
5000ml
Reg Date
2021-05-19
Expired Date
2026-05-18
Company Name
Baxter Holding BV
Production Company Name
BIEFFE MEDITAL SPA
Company Detail Path
/organization/baxter-holding-bv
Production Company Detail Path
/organization/bieffe-medital-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 19, 2021
Approval ID
887M32hPnv9
Type
化学药品
Back to NMPA Approvals
